0001493152-21-018317.txt : 20210802 0001493152-21-018317.hdr.sgml : 20210802 20210802164548 ACCESSION NUMBER: 0001493152-21-018317 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210723 FILED AS OF DATE: 20210802 DATE AS OF CHANGE: 20210802 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sassi Nir CENTRAL INDEX KEY: 0001760673 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40652 FILM NUMBER: 211136641 MAIL ADDRESS: STREET 1: 3 ELUL STREET, APT. 6 CITY: MODIIN STATE: L3 ZIP: 7176397 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Intec Parent Inc. CENTRAL INDEX KEY: 0001857044 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 863158720 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12 HARTOM STREET STREET 2: HAR HOTZVIM CITY: JERUSALEM STATE: L3 ZIP: 9777512 BUSINESS PHONE: 972-2-586-4657 MAIL ADDRESS: STREET 1: 12 HARTOM STREET STREET 2: HAR HOTZVIM CITY: JERUSALEM STATE: L3 ZIP: 9777512 3 1 ownership.xml X0206 3 2021-07-23 0 0001857044 Intec Parent Inc. NTEC 0001760673 Sassi Nir C/O INTEC PARENT, INC. 12 HARTOM STREET JERUSALEM L3 9777512 ISRAEL 0 1 0 0 Chief Financial Officer Stock Option (right to buy) 331.2 2026-03-27 Common Stock 41 D Stock Option (right to buy) 357.3 2026-07-25 Common Stock 500 D Stock Option (right to buy) 436.8 2024-07-05 Common Stock 625 D Stock Option (right to buy) 415.2 2025-01-02 Common Stock 625 D Stock Option (right to buy) 610.2 2026-01-22 Common Stock 1125 D Stock Option (right to buy) 72 2026-09-13 Common Stock 2500 D Stock Option (right to buy) 34.3 2027-02-17 Common Stock 1125 D Stock Option (right to buy) 25.7 2027-09-16 Common Stock 1250 D Stock Option (right to buy) 357.3 2026-07-25 Common Stock 500 D The stock options are fully vested and are exercisable. The options vest and become exercisable as to one-third of the total shares on January 22, 2020 and thereafter the remaining shares vest and become exercisable in equal quarterly installments through January 22, 2022. The options vest and become exercisable as to one-third of the total shares on September 13, 2020 and thereafter the remaining shares vest and become exercisable in equal quarterly installments through September 13, 2022. The options vest and become exercisable as to one-third of the total shares on February 17, 2021 and thereafter the remaining shares vest and become exercisable in equal quarterly installments through February 17, 2023. The options vest and become exercisable in full on December 31, 2021. The options become fully vested only in the event that a material agreement is entered into between the Company and a third party. /s/ Nir Sassi 2021-08-02